| Serial Number | 99007812 |
| Word Mark | XTURNPOINT |
| Filing Date | Friday, January 17, 2025 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Tuesday, October 14, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | NOT AVAILABLE |
| Description of Mark | The mark consists of the stylized wording "XTURNPOINT" on a black rectangle. The enclosed white spaces appearing in the mark drawing are transparent areas and are not being claimed as a feature of the mark. |
| Pseudo Mark | X TURN POINT |
| Goods and Services | Providing venture capital, development capital, private equity and investment funding; Venture capital services, namely, providing financing to emerging and start-up companies; Providing venture capital, development capital, private equity and investment funding for the development of biologics, biosimilars, pharmaceuticals, and therapeutics; Venture capital services, namely, providing financing to emerging and start-up companies for the development of biologics, biosimilars, pharmaceuticals, and therapeutics |
| Indication of Colors claimed | The color(s) black is/are claimed as a feature of the mark. |
| Goods and Services | Business consulting services; Business consulting services related to biologics, biosimilars, pharmaceuticals, and therapeutics; Market analysis and research services; Business advice and analysis of markets; Market analysis and research services related to biologics, biosimilars, pharmaceuticals, and therapeutics; Business advice and analysis of markets related to biologics, biosimilars, pharmaceuticals, and therapeutics |
| Goods and Services | Research and development of biologics, biosimilars, pharmaceuticals, and therapeutics; Providing information in the field of scientific and medical research related to biologics, biosimilars, pharmaceuticals, and therapeutics |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 17, 2025 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 036 - Insurance; financial affairs; monetary affairs; real estate affairs. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 17, 2025 |
| Primary Code | 036 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 17, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Xentria, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Chicago, IL 60631 |
| Event Date | Event Description |
| Friday, January 17, 2025 | NEW APPLICATION ENTERED |
| Friday, June 27, 2025 | ASSIGNED TO EXAMINER |
| Tuesday, July 8, 2025 | NON-FINAL ACTION WRITTEN |
| Tuesday, July 8, 2025 | NON-FINAL ACTION E-MAILED |
| Sunday, June 22, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, October 8, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, October 8, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, October 14, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, July 8, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |